Savara Pharmaceuticals
SVRA
#6301
Rank
โ‚น52.17 B
Marketcap
โ‚น316.99
Share price
4.72%
Change (1 day)
10.41%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -โ‚น22.99

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น23.54. In 2022 the company made an earnings per share (EPS) of -โ‚น21.02 an increase over its 2021 EPS that were of -โ‚น28.59.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น22.999.36%
2022-โ‚น21.02-26.47%
2021-โ‚น28.59-59.52%
2020-โ‚น70.63-56.48%
2019-โ‚น162.282.66%
2018-โ‚น158.07-38.56%
2017-โ‚น257.29-71.06%
2016-โ‚น889.09-37.06%
2015-โ‚น1,4134.35%
2014-โ‚น1,354-25.81%
2013-โ‚น1,825-8.82%
2012-โ‚น2,001-27.66%
2011-โ‚น2,766-58.41%
2010-โ‚น6,651-86%
2009-โ‚น47,4964.13%
2008-โ‚น45,61324%
2007-โ‚น36,785-35.9%
2006-โ‚น57,38495%
2005-โ‚น29,42853.85%
2004-โ‚น19,12844.44%
2003-โ‚น13,242-40%
2002-โ‚น22,071

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น84.08 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น22.70-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA